Inflammatory bowel disease: Experience of two Chilean centers;Enfermedades inflamatorias intestinales: Experiencia de dos centros chilenos

Revista Medica de Chile

Volumn 133, Issue 11, 2005, Pages 1295-1304

  Figueroa C, Carolina ^a,c   Quera P, Rodrigo ^a,b   Valenzuela E, Jorge ^a,b   Jensen B, Christian ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

^c Depto 304   (Chile)

Author keywords

Colitis; Crohn disease; Inflammatory bowel disease; Ulcerative

Indexed keywords

ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CHILE; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIOECONOMICS; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS; CHI-SQUARE DISTRIBUTION; CHILE; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 31144476808     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. RUSSEL MG, STOCKBRUGGER RW. Epidemiology of Inflammatory Bowel Disease: an update. Scand J Gastroenterol 1996; 31: 417-27.
2. SHAH SA, PEPPERCORN MA. Inflammatory bowel disease therapy: an update. Compr Ther 1995; 21: 296-302.
3. LOFTUS EV JR, SANDBORN WJ. Epidemiology of Inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 1-20.
4. LOFTUS EV JR. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.
5. PODOLSKY DK. Inflammatory bowel disease (1). N Engl J Med 1991; 325: 928-37.
6. BLUMBERG S, WARNEN S. Prospects for research in inflammatory bowel disease. JAMA 2001; 285: 643-47.
7. MONSEN U, BERNELL O, JOHANSSON C, HELLERS G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol 1991; 26: 302-6.
8. LAKATOS L, MESTER G, ERDELYI Z, BALOGH M, SZIPOCS I, KAMARAS G ET AL. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol 2004; 10: 404-9.
9. FONAGER K, SORENSEN HT, OLSEN J. Change in Incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the national registry of patients, 1981-1992. Int J Epidemiol 1997; 26: 1003-8.
10. SHIVANANDA S, PENA AS, MAYBERRY JF, RUITENBERG EJ, HOEDEMAEKER PJ. Epidemiology of proctocolitis in the region of Leiden, The Netherlands. A population study from 1979-1983. Scand J Gastroenterol 1987; 22: 993-1002.
11. HELLERS G. Crohn's disease in Stockholm county, 1955-1974: a study of epidemiology, result of surgical treatment and long term prognosis. Acta Chir Scand Suppl 1979; 490: 1-84.
12. BERNER J, KIAER T. Ulcerative colitis and Crohn's disease on the Faroe Islands 1964-1983. A retrospective epidemiological survey. Scand J Gastroenterol 1986; 21: 188-92.
13. STONNINGTON CM, PHILLIPS SF, MELTON LJ 3RD, ZINSMEISTER AR. Chronic ulcerative colitis: Incidence and prevalence in a community. Gut 1987; 28: 402-9.
14. SHIVANANDA S, LENNARD-JONES J, LOGAN R, FEAR N, PRICE A, CARPENTER L ET AL. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7.
15. ILABACA M, TOLEDO C, JIMÉNEZ P. Colitis ulcerosa idiopática: Una enfermedad mejor reconocida. Gastr Latinoam 2001; 12: 274 (resumen).
16. IBÁÑEZ P, VERGARA MT. Enfermedad inflamatoria intestinal: Características clínicas de una población en control. Gastr Latinoam 2001; 12: 275 (resumen).
17. RODRIGO L, RIESTRA S, NIÑO P, CADAHÍA V, TOJO R, FUENTES D ET AL. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004; 96: 296-305.
18. ROSE JD, ROBERTS GM, WILLIAMS G, MAYBERRY JF, RHODES J. Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut 1988; 29: 346-51.
19. SEDLACK RE, WHISNANT J, ELVEBACK LR, KURLAND LT. Incidence of Crohn's disease in Olmsted County, Minnesota, 1935-1975. Am J Epidemiol 1980; 112: 759-63.
20. SONNENBERG A. Geographic variation in the incidence of and mortality from inflammatory bowel disease. Dis Colon Rectum 1986; 29: 854-61.
21. MUNKHOLM P, LANGHOLZ E, NIELSEN OH, KREINER S, BINDER V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609-14.
22. LEONG RW, LAU JY, SUNG JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004; 10: 646-51.
23. NUNES GC, AHLQUIST RE JR. Increasing incidence of Crohn's disease. Am J Surg 1983; 145: 578-81.
24. THOMAS GA, MILLAR-JONES D, RHODES J, ROBERTS GM, WILLIAMS GT ET AL. Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol 1995; 7: 401-5.
25. APPLEYARD C, HERNÁNDEZ G, RÍOS-BEDOYA CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 2004; 10; 106-11.
26. SOUZA MH, TRONCON LE, RODRIGUES CM, VIANA CF, ONOFRE PH, MONTEIRO RA ET AL. Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in Southeastern Brazil. Arq Gastroenterol 2002; 39: 98-105.
27. LINARES DE LA CAL JA, CANTON C, HERMIDA C, PÉREZMIRANDA M, MATE-JIMÉNEZ J. Estimated incidence of inflammatory bowel disease in Argentina and Panama (1987-1993). Rev Esp Enferm Dig 1999; 91: 277-86.
28. MOUM B, EKBOM A. Epidemiology of inflammatory bowel disease- methodological considerations. Dig Liver Dis 2002; 34: 364-9.
29. HAY JW, HAY AR. Inflammatory bowel disease: cost-of-illness. J Clin Gastroenterol 1992; 14: 309-17.
30. a ed Philadelphia: WB Saunders; 1998; 1735-61.
31. SEO M, OKADA M, YAO T, OKABE N, MAEDA K, OH K. Evaluation of disease activity in patients with moderately active colitis: comparisons between a new activity index and Truelove and Witt's classification. Am J Gastroenterol 1995; 90: 1759-63.
32. a ed Philadelphia: WB Saunders; 1998; 1735-61.
33. LAKATOS L, PANDUR T, DAVID G, BALOGH Z, KURONYA P, TOLLAS A ET AL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of Western Hungary with disease phenotype: Results of a 25-year follow-up study. World J Gastroenterol 2003; 9: 2300-7.
34. TRIANTAFILLIDIS JK, EMMANOUILIDIS A, MANOUSOS ON, POMONIS E, TSITSA C, CHERACAKIS P ET AL. Ulcerative colitis in Greece: clinicoepidemiological data, course and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998; 27: 204-10.
35. a ed Philadelphia: WB Saunders; 1998; 1708-34.
36. RIEGLER G, TARTAGLIONE MT, CARRATÚ R, D'INCA R, VALPIANI D, RUSSO MI ET AL. Age -related clinical severity at diagnosis in 1705 patients with ulcerative colitis. A study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000; 45: 462-5.
37. GOWER-ROUSSEAU C, SALOMEZ JL, DUPAS JL, MARTI R, NUTTENS MC, VOTTE A ET AL. Incidence of inflammatory bowel disease in Northern France (1988-1990). Gut 1994; 35: 1433-8.
38. TRIANTAFILLIDIS JK, EMMANOUILIDIS A, MANOUSOS O, NICOLAKIS D, KOGEVINAS M. Clinical patterns of Crohn's disease in Greece: a follow-up study of 155 cases. Digestion 2000; 61: 121-8.
39. MINTZ R, FELLER ER, BAHR RL, SHAH SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 135-9.
40. HERFARTH H, ROGLER G. Inflammatory bowel disease. Endoscopy 2005; 37: 42-7.
41. JENSEN C, VALLEJO J, VERGARA JI, AZOLAS C, PÉREZ G, GARRIDO R ET AL. Enfermedad de Crohn y cirugía. Rev Chil Cir 1997; 49: 82-7.
42. DAPERNO M, SOSTEGNI R, LAVAGNA A, CROCELLA L, ERCOLE E, RIGAZIO C ET AL. The role of endoscopy in inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2004; 8: 209-14.
43. LENNARD-JONES JE, SHIVANANDA S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 1997; 9: 353-9.
44. VALERA JM, PONIACHIK J, VALENZUELA J. Enfermedad de Crohn: Enfoque terapéutico. Gastr Latinoam 2002; 4: 270-80.
45. DUBINSKY MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy and safety. Clin Gastroenterol Hepatol 2004; 2: 731-3.
46. HILDSEN R, VERHOEF M, BEST A, POCOBELLI G. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. BMC Gastroenterology 2003; 3: 10.